Status:
UNKNOWN
Calcium Supplementation to Prevent Preeclampsia in Sichuan Province of China
Lead Sponsor:
West China Second University Hospital
Collaborating Sponsors:
Sichuan Academy of Medical Sciences
Guang'an people's hospital of Sichuan province
Conditions:
Preeclampsia
Eligibility:
FEMALE
Phase:
NA
Brief Summary
the purpose of this study is to determine whether calcium supplementation is effective to prevent preeclampsia in Sichuang Province of china and which dose is more suitable
Eligibility Criteria
Inclusion
- Nulliparity;age ≥35 years;Previous pre-eclampsia;Family history of pre-eclampsia;Multiple pregnancy;Time between pregnancies ≥10years;Body mass index ≥25;diastolic pressure ≥ 80 mm Hg before 20 weeks' gestation;Proteinuria ≥+ on more than one occasion or ≥ 300 mg/24 h before 20 weeks' gestation;Underlying medical conditions(Pre-existing hypertension;Pre-existing renal disease;Pre-existing diabetes;Presence of antiphospholipid antibodies;Chronic autoimmune disease);male sex partner's predecessor wife has Previous pre-eclampsia
Exclusion
- first prenatal visit after 16 weeks' gestation;severe anemia;other Underlying medical conditions which need treatment first (such as uncontrolled hyperthyreosis )
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
11000 Patients enrolled
Trial Details
Trial ID
NCT01806454
Start Date
October 1 2013
Last Update
August 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chengdu, China